These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33906835)

  • 1. Association between varying cut-points of intermediate hyperglycemia and risk of mortality, cardiovascular events and chronic kidney disease: a systematic review and meta-analysis.
    Gujral UP; Jagannathan R; He S; Huang M; Staimez LR; Wei J; Singh N; Narayan KMV
    BMJ Open Diabetes Res Care; 2021 Apr; 9(1):. PubMed ID: 33906835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
    J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between prediabetes (defined by HbA1
    Kim GS; Oh HH; Kim SH; Kim BO; Byun YS
    BMC Nephrol; 2019 Apr; 20(1):130. PubMed ID: 30992067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis.
    Huang Y; Cai X; Mai W; Li M; Hu Y
    BMJ; 2016 Nov; 355():i5953. PubMed ID: 27881363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Serum 25-Hydroxyvitamin D With Cardiovascular Outcomes and All-Cause Mortality in Individuals With Prediabetes and Diabetes: Results From the UK Biobank Prospective Cohort Study.
    Zhang P; Guo D; Xu B; Huang C; Yang S; Wang W; Liu W; Deng Y; Li K; Liu D; Lin J; Wei X; Huang Y; Zhang H
    Diabetes Care; 2022 May; 45(5):1219-1229. PubMed ID: 35226734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes.
    Li M; Zhao Z; Qin G; Chen L; Lu J; Huo Y; Chen L; Zeng T; Xu M; Chen Y; Wang T; Wang S; Xu Y; Shi L; Tang X; Su Q; Yu X; Yan L; Wan Q; Chen G; Gao Z; Wang G; Shen F; Luo Z; Zhang Y; Liu C; Wang Y; Hu R; Ye Z; Wu S; Deng H; Yang T; Li Q; Qin Y; Mu Y; Zhao J; Ning G; Bi Y; Xu Y; Wang W
    Metabolism; 2021 Nov; 124():154874. PubMed ID: 34517014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking cessation for secondary prevention of cardiovascular disease.
    Wu AD; Lindson N; Hartmann-Boyce J; Wahedi A; Hajizadeh A; Theodoulou A; Thomas ET; Lee C; Aveyard P
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD014936. PubMed ID: 35938889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of chronic kidney disease defined by decreased estimated glomerular filtration rate in individuals with different prediabetic phenotypes: results from a prospective cohort study in China.
    Li W; Wang A; Jiang J; Liu G; Wang M; Li D; Wen J; Mu Y; Du X; Gaisano H; Dou J; He Y
    BMJ Open Diabetes Res Care; 2020 Apr; 8(1):. PubMed ID: 32245825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose Study.
    Parizadeh D; Rahimian N; Akbarpour S; Azizi F; Hadaegh F
    Eur J Prev Cardiol; 2019 Jul; 26(10):1080-1091. PubMed ID: 30862232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis.
    Cai X; Zhang Y; Li M; Wu JH; Mai L; Li J; Yang Y; Hu Y; Huang Y
    BMJ; 2020 Jul; 370():m2297. PubMed ID: 32669282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Prediabetes With CKD Progression and Adverse Cardiovascular Outcomes: An Analysis of the CRIC Study.
    Neves JS; Correa S; Baeta Baptista R; Bigotte Vieira M; Waikar SS; Mc Causland FR
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1772-80. PubMed ID: 31943096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of combined healthy lifestyle with risk of adverse outcomes in patients with prediabetes.
    Xu X; Li J; Yu Y; Tan X; Xu F; Wang B; Wang N; Lu Y
    Diabetes Metab Res Rev; 2024 May; 40(4):e3795. PubMed ID: 38546142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study.
    Kabootari M; Asgari S; Ghavam SM; Abdi H; Azizi F; Hadaegh F
    J Transl Med; 2021 Jun; 19(1):277. PubMed ID: 34193200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis.
    Huang Y; Cai X; Chen P; Mai W; Tang H; Huang Y; Hu Y
    Ann Med; 2014 Dec; 46(8):684-92. PubMed ID: 25230915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin for the primary prevention of cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.
    Pallikadavath S; Ashton L; Brunskill NJ; Burton JO; Gray LJ; Major RW
    Eur J Prev Cardiol; 2022 Feb; 28(17):1953-1960. PubMed ID: 34448849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysglycemia/prediabetes and cardiovascular risk factors.
    Hanna-Moussa A; Gardner MJ; Kurukulasuriya LR; Sowers JR
    Rev Cardiovasc Med; 2009; 10(4):202-8. PubMed ID: 20065930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship Between Major Food Sources of Fructose and Cardiovascular Outcomes: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies.
    Sun T; Zhang Y; Ding L; Zhang Y; Li T; Li Q
    Adv Nutr; 2023 Mar; 14(2):256-269. PubMed ID: 36803836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
    Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005-2018.
    Ding L; Zhang H; Dai C; Zhang A; Yu F; Mi L; Qi Y; Tang M
    Cardiovasc Diabetol; 2024 Feb; 23(1):84. PubMed ID: 38419029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.